Adherence to Therapies in Patients with Type 2 Diabetes

被引:473
作者
Garcia-Perez, Luis-Emilio [1 ]
Alvarez, Maria [2 ]
Dilla, Tatiana [2 ]
Gil-Guillen, Vicente [3 ]
Orozco-Beltran, Domingo [3 ]
机构
[1] Lilly SA, Dept Med, Global Med Affairs, Ave Ind 30, Madrid 28108, Spain
[2] Lilly SA, Dept Med, Madrid 28108, Spain
[3] Univ Miguel Hernandez, Cathedra Family Med, Dept Clin Med, Alicante, Spain
关键词
Adherence; Dosing complexity; Glycemic control; Primary care; Type; 2; diabetes; FIXED-DOSE COMBINATION; PSYCHOLOGICAL INSULIN-RESISTANCE; HEALTH-CARE OUTCOMES; LONG-TERM ADHERENCE; MEDICATION ADHERENCE; GLYCEMIC CONTROL; ANTIDIABETIC THERAPY; UNITED-STATES; DUAL THERAPY; HYPOGLYCEMIC MEDICATION;
D O I
10.1007/s13300-013-0034-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adherence to therapy is defined as the extent to which a person's behavior in taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a healthcare provider. Patients presenting with type 2 diabetes mellitus are initially encouraged to maintain a healthy diet and exercise regimen, followed by early medication that generally includes one or more oral hypoglycemic agents and later may include an injectable treatment. To prevent the complications associated with type 2 diabetes, therapy frequently also includes medications for control of blood pressure, dyslipidemia and other disorders, since patients often have more than three or four chronic conditions. Despite the benefits of therapy, studies have indicated that recommended glycemic goals are achieved by less than 50% of patients, which may be associated with decreased adherence to therapies. As a result, hyperglycemia and long-term complications increase morbidity and premature mortality, and lead to increased costs to health services. Reasons for nonadherence are multifactorial and difficult to identify. They include age, information, perception and duration of disease, complexity of dosing regimen, polytherapy, psychological factors, safety, tolerability and cost. Various measures to increase patient satisfaction and increase adherence in type 2 diabetes have been investigated. These include reducing the complexity of therapy by fixed-dose combination pills and less frequent dosing regimens, using medications that are associated with fewer adverse events (hypoglycemia or weight gain), educational initiatives with improved patient-healthcare provider communication, reminder systems and social support to help reduce costs. In the current narrative review, factors that influence adherence to different therapies for type 2 diabetes are discussed, along with outcomes of poor adherence, the economic impact of nonadherence, and strategies aimed at improving adherence.
引用
收藏
页码:175 / 194
页数:20
相关论文
共 99 条
[1]  
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]
[2]   Patient adherence to medication requirements for therapy of type 2 diabetes [J].
Bailey, C. J. ;
Kodack, M. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (03) :314-322
[3]   Fixed-dose single tablet antidiabetic combinations [J].
Bailey, C. J. ;
Day, C. .
DIABETES OBESITY & METABOLISM, 2009, 11 (06) :527-533
[4]   Fixed-Dose Combination Antidiabetic Therapy: Real-World Factors Associated with Prescribing Choices and Relationship with Patient Satisfaction and Compliance [J].
Benford, Mike ;
Milligan, Gary ;
Pike, James ;
Anderson, Peter ;
Piercy, James ;
Fermer, Steve .
ADVANCES IN THERAPY, 2012, 29 (01) :26-40
[5]   Costs and Benefits Associated With Diabetes Education A Review of the Literature [J].
Boren, Suzanne A. ;
Fitzner, Karen A. ;
Panhalkar, Pallavi S. ;
Specker, James E. .
DIABETES EDUCATOR, 2009, 35 (01) :72-96
[6]   Relationship of blood pressure control to adherence with anti hypertensive monotherapy in 13 managed care organizations [J].
Bramley, TJ ;
Gerbino, PP ;
Nightengale, BS ;
Frech-Tamas, F .
JOURNAL OF MANAGED CARE PHARMACY, 2006, 12 (03) :239-245
[7]   The direct medical cost of type 2 diabetes [J].
Brandle, M ;
Zhou, HH ;
Smith, BRK ;
Marriott, D ;
Burke, R ;
Tabaei, BP ;
Brown, MB ;
Herman, WH .
DIABETES CARE, 2003, 26 (08) :2300-2304
[8]  
Breitscheidel L, 2010, J Med Econ, V13, P8, DOI 10.3111/13696990903479199
[9]   Illness and Treatment Perceptions Are Associated With Adherence to Medications, Diet, and Exercise in Diabetic Patients [J].
Broadbent, Elizabeth ;
Donkin, Liesje ;
Stroh, Julia C. .
DIABETES CARE, 2011, 34 (02) :338-340
[10]   One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice [J].
Buysschaert, M. ;
Preumont, V. ;
Oriot, P. R. ;
Paris, I. ;
Ponchon, M. ;
Scarniere, D. ;
Selvais, P. .
DIABETES & METABOLISM, 2010, 36 (05) :381-388